Historique
Brochure
Hepatitis C transmission and injecting drug use: harm reduction responses
Auteur(s) :
REID, L. ;
ELLIS, D. ;
MERKINAITE, S. ;
SCHATZ, E. ;
PRINS-SCHIFFER, K. ;
MAJO ROCA, F. X. ;
LEICHT, A.
Année
2010
Page(s) :
68 p.
Langue(s) :
Anglais
Éditeur(s) :
Vilnius [Lithuania] : EHRN (Eurasian Harm Reduction Network)
;
Amsterdam : Correlation - European Network Social Inclusion and Health
Domaine :
Drogues illicites / Illicit drugs
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Thésaurus géographique
EUROPE
Thésaurus mots-clés
HEPATITE
;
RECOMMANDATION
;
INTERVENTION
;
PREVENTION
;
DEPISTAGE
;
INJECTION
;
POPULATION A RISQUE
Note de contenu :
Section 1: Introduction and overview
1.1. Hepatitis C and injecting drug use in Europe
1.2. Key issues and challenges
1.2.1. Political will and leadership
1.2.2. Prevention, diagnosis, treatment and care
1.3. Responding to hepatitis C: examples of good practice
Section 2: Hepatitis C prevention and diagnosis
2.1. Increasing public awareness of blood borne viruses in the United Kingdom
2.2. Increasing detection of viral hepatitis in Germany
2.3. Education and peer support in Scotland, United Kingdom
2.4. Preventing transmission of HCV among IDUs in Germany
2.5.. Reaching additional risk groups: non-opiate injections in Scotland
Section 3: Hepatitis C treatment, care and support
3.1. Reaching most at risk groups: prison-based HCV interventions in Scotland, United Kingdom
3.2. Comprehensive treatment, care and post-treatment support in the Netherlands
3.3. Multidisciplinary services of injecting drug users in Switzerland
Section 4: Building comprehensive responses
4.1. Training networks for professionals in Austria
4.2. Mobilizing advocacy for hepatitis C in Eastern Europe and Central Asia
Section 5: Conclusion and recommendations
1.1. Hepatitis C and injecting drug use in Europe
1.2. Key issues and challenges
1.2.1. Political will and leadership
1.2.2. Prevention, diagnosis, treatment and care
1.3. Responding to hepatitis C: examples of good practice
Section 2: Hepatitis C prevention and diagnosis
2.1. Increasing public awareness of blood borne viruses in the United Kingdom
2.2. Increasing detection of viral hepatitis in Germany
2.3. Education and peer support in Scotland, United Kingdom
2.4. Preventing transmission of HCV among IDUs in Germany
2.5.. Reaching additional risk groups: non-opiate injections in Scotland
Section 3: Hepatitis C treatment, care and support
3.1. Reaching most at risk groups: prison-based HCV interventions in Scotland, United Kingdom
3.2. Comprehensive treatment, care and post-treatment support in the Netherlands
3.3. Multidisciplinary services of injecting drug users in Switzerland
Section 4: Building comprehensive responses
4.1. Training networks for professionals in Austria
4.2. Mobilizing advocacy for hepatitis C in Eastern Europe and Central Asia
Section 5: Conclusion and recommendations
Résumé :
This booklet was produced within working package 7 under coordination of the Eurasian Harm Reduction Network (EHRN) and provides an overview about Hepatitis C and injecting drug use in Europe, including best practice examples as response to the epidemic.
Affiliation :
Lithuania / Lituanie